BofA update shows where active managers are putting money
Vital Farms Inc. stock reached a new 52-week high, trading at 48.28 USD. This milestone reflects the company’s strong performance over the past year, marked by a 53% increase in its stock price. With a market capitalization of $2.14 billion, the company has demonstrated robust revenue growth of 21.5% in the last twelve months. According to InvestingPro data, analysts maintain a strong buy consensus, with price targets ranging from $48 to $60. The impressive growth can be attributed to Vital Farms’ expanding market presence and consumer demand for its sustainable and ethically-produced food products. As the company continues to capitalize on these trends, investors have shown increased confidence, driving the stock to this new high. InvestingPro analysis indicates the stock is currently trading near its Fair Value, with a "GREAT" overall financial health score. Discover 14 additional exclusive ProTips and comprehensive analysis in the Pro Research Report.
In other recent news, Vital Farms has garnered significant attention from several analyst firms, with multiple revisions to its stock price targets. Mizuho (NYSE:MFG) raised its price target to $53, maintaining an Outperform rating, citing strong sales and EBITDA performance along with improvements in the supply chain. DA Davidson also increased its price target to $52, highlighting capacity growth and increased consumer awareness as key factors. TD Cowen adjusted its target to $48 following Vital Farms’ second-quarter results, which surpassed expectations, and noted that management raised its 2025 guidance above consensus estimates. Morgan Stanley (NYSE:MS) also set a $48 target, emphasizing the company’s growth outlook and projecting a 21% compound annual growth rate in revenue from 2025 to 2027. These developments reflect a positive sentiment among analysts regarding Vital Farms’ future performance, driven by operational improvements and strategic growth initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.